Shopify: Analysts Anticipate Q2 Earnings Of $0.07 Per Share

Shopify (NYSE: SHOP) will be reporting its second quarter financial results on July 28 before the market opens. Analysts have a consensus $1,559.21 12-month price target on the company, via a total of 41 analysts, with 10 analysts having strong buy ratings. 14 analysts meanwhile have buy ratings, 15 have hold ratings, 1 analyst has a sell rating and 1 has a strong sell rating on the company. The street high comes from National Bank with a $2,000 price target, and the lowest target sits at $825 from Veritas Investment.

31 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 31 analysts is $1.04 billion; this number has been revised upwards from $900 million at the start of the year. The highest revenue estimate is $1.13 billion, while the lowest is $866.67 million.

Onto EBITDA estimates, there are currently 13 analysts who have second-quarter EBITDA estimates. The mean is currently $116.45 million, with this number having been revised down from $125.40 million at the start of the year. The street high estimate currently sits at $177.50 million in EBITDA and the lowest is $54.75 million.

Analysts estimate that quarterly earnings per share will come in at $0.07, with this number being revised down from $0.15 at the start of the year. Street high is $0.44 and the lowest estimate is -$0.56 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Meghan Markle’s Half-Brother Submitted Evidence Against Their Father, But Now Faces Philippine Police Scrutiny

Related News

Cronos: Raymond James Reiterates Price Target After PharmaCann Investment

Yesterday, Cronos Group (TSX: CRON) showed once again that the demand for U.S cannabis assets...

Tuesday, June 15, 2021, 05:50:00 PM

Sundial: Analysts Expect Positive EBITDA For Q3 2021

Sundial Growers (NASDAQ: SNDL) announced that they will be reporting their third quarter financials after...

Tuesday, November 9, 2021, 05:18:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Ayr Strategies: PI Financial Initiates With $60 Price Target, Buy Rating

On January 20th, PI Financial became the fourth firm to cover Ayr Strategies’ (CSE: AYR.a)....

Sunday, January 24, 2021, 11:34:00 AM

Jushi Holdings: Canaccord Raises Price Target Following Virginia News

On Saturday, both the Virginia House and Senate approved a recreational cannabis bill, which will...

Tuesday, March 2, 2021, 02:47:00 PM